+ Follow DR. ALESSANDRO BANCHI Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 377131
[Title] => Millions in developing nations have HIV/AIDS
[Summary] =>
Some 40 million people worldwide are currently infected with Human Immuno Deficiency Virus-Acquired Immune Deficiency Syndrome (HIV/AIDS). Ninety-five percent live in developing countries.
Another sobering thought: most of the 2.3 million HIV-positive children were infected through their mothers.
[DatePublished] => 2006-12-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 184877
[Title] => New treatment of early Parkinsons disease cited
[Summary] => VIENNA, Austria A preferable option for first-line treatment of Parkinsons disease (PD) identified as pramipexole (Sifrol and Mirapex), was discussed by experts at the 6th Congress of the European Federation of Neurological Societies (EFNS) here.
Pramipexole (pramipexole dihydrochloride tablets), earlier approved in the United States for treating the disease in its early stages, was also recommended for the same purpose in Europe. This complies with new guidelines for managing Parkinsons disease, issued in June 2001.
[DatePublished] => 2002-11-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
DR. ALESSANDRO BANCHI
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 377131
[Title] => Millions in developing nations have HIV/AIDS
[Summary] =>
Some 40 million people worldwide are currently infected with Human Immuno Deficiency Virus-Acquired Immune Deficiency Syndrome (HIV/AIDS). Ninety-five percent live in developing countries.
Another sobering thought: most of the 2.3 million HIV-positive children were infected through their mothers.
[DatePublished] => 2006-12-28 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 184877
[Title] => New treatment of early Parkinsons disease cited
[Summary] => VIENNA, Austria A preferable option for first-line treatment of Parkinsons disease (PD) identified as pramipexole (Sifrol and Mirapex), was discussed by experts at the 6th Congress of the European Federation of Neurological Societies (EFNS) here.
Pramipexole (pramipexole dihydrochloride tablets), earlier approved in the United States for treating the disease in its early stages, was also recommended for the same purpose in Europe. This complies with new guidelines for managing Parkinsons disease, issued in June 2001.
[DatePublished] => 2002-11-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
December 28, 2006 - 12:00am
November 21, 2002 - 12:00am